Clinical Research, Consulting
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
87
NCT05607004
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Phase: Phase 2
Role: Collaborator
Start: Feb 14, 2023
Completion: Apr 30, 2027
Loading map...